Displaying 221 - 230 of 243
Alternative Name: Tripterygium wilfordii derivatives, including triptolide
Active Status: No
User: Male
Mode: No
Developer: WHO, University of California at Los Angeles
Project Stage: Lead Optimization
Alternative Name: Testosterone undecanoate (TU) + etonogestrel (ENG)
Active Status: No
User: Male
Mode: Yes
Delivery Type: Injectable, Subdermal
Developer: Organon
Project Stage: Phase II
Alternative Name: Testosterone undecanoate (TU) + norethisterone enanthate (NET-EN)
Active Status: No
User: Male
Mode: Yes
Delivery Type: Injectable
Developer: Bayer HealthCare, CONRAD, WHO
Project Stage: Phase II
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: FHI 360, GE Healthcare
Project Stage: Prototype Development
Alternative Name: LNG Contraceptive IUS 12 (LCS12)
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Bayer HealthCare
Project Stage: Regulatory
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Population Council, Theramex, Rockefeller Foundation
Project Stage: Marketed
Alternative Name: Ulipristal acetate (UPA) Intrauterine System (IUS)
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: HRA Pharma, Population Council
Project Stage: Phase I
Alternative Name: Ulipristal acetate (UPA) vaginal ring
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Vaginal Ring
Developer: Population Council, HRA Pharma
Project Stage: Phase II
Alternative Name: S-003296
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal Gel
Developer: Central Drug Research Institute, India
Project Stage: Pre-clinical
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Vaginal, Other
Developer: University of Texas Health Science Center at San Antonio
Project Stage: Lead Optimization
Pages
